ACPU
AGN

Arrowgrass Capital Partners (US)’s Allergan Inc AGN Stock Holding History

Arrowgrass Capital Partners (US)’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,797,864
Closed -$382M – 605
2014
Q4 		$382M Buy
1,797,864
+1,292,995
+256% +$257M 6.79% 3
2014
Q3 		$90M Sell
504,869
-229,119
-31% -$38.1M 2.18% 7
2014
Q2 		$124M Buy
+733,988
New +$114M 3.66% 6
2014
Q1 		– Sell
-27,500
Closed -$3.06M – 233
2013
Q4 		$3.06M Buy
+27,500
New +$2.63M 0.14% 105

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Arrowgrass Capital Partners (US)'s AGN Position: Q1 2015 in Review

Arrowgrass Capital Partners (US) sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,797,864 shares — an estimated $382M sold.

Arrowgrass Capital Partners (US) first reported a position in AGN in Q4 2013 and held it in 4 quarters. The position peaked at $382M in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Arrowgrass Capital Partners (US) reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Arrowgrass Capital Partners (US) sold 1,797,864 Allergan Inc shares in Q1 2015, an estimated $382M.
  • Arrowgrass Capital Partners (US) first reported a position in Allergan Inc in Q4 2013 and held it in 4 quarters.
  • Arrowgrass Capital Partners (US)'s Allergan Inc position peaked at $382M in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Arrowgrass Capital Partners (US)'s 13F filing for Q1 2015, filed 15 May 2015.